Replies to post #198441 on Cytodyn Inc (CYDY)

[justdafactss]

From your adisinsight.springer.com link---



https://adisinsight.springer.com/search

Sorry, no nash licensing available for a Phase 2.

Be sure to click the "5 Safety Reports" tab where 1 SERIOUS ADR (adverse drug reaction case report) was reported on Oct 18, 2021.

An event is determined to be serious (based on the ICH definition) when the patient outcome is:
death
life-threatening
hospitalisation
disability
congenital anomaly
other medically important event

CYDY looks like a fool again.

Oooooooo lookey, says Licenced by: IncellDx

LAUGHING

[HyGro]

NP has been hyping the stock repeatedly for several years and has shown he is unsuccessful at it. He hyped mTNBC data and got 2 hours of a few pennies and then it dropped back to no gain. Hyped the NASH 350 mg open label data and same thing happened -- no sustainable share price impact.

NP has no credibility now and hasn't successful raised the price in all of 2021 -- share price is down >50% since beginning of the year. And NP's been working all year to raise the price so he can raise cash to keep the lights on. But he has no credibility anymore.